Publications by authors named "Ronald Zwrtek"

Claim this Profile
E
Endocrine therapy with or without whole breast irradiation in low-risk breast cancer patients after breast-conserving surgery: 10-year results of the Austrian Breast and Colorectal Cancer Study Group 8A trial.
Gerd Fastner, Felix Sedlmayer, Joachim Widder, Martina Metz, Hans Geinitz, Ronald Zwrtek

Eur J Cancer· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
â
• Pancho trial (p53-adapted neoadjuvant chemotherapy for resectable esophageal cancer) completed-mutation rate of the marker higher than expected.
Sonja Kappel-Latif, Johannes Zacherl, Michael Hejna, Maria Westerhoff, Dietmar Tamandl, Ronald Zwrtek

Eur Surg· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The biomarker TP53 divides patients with neoadjuvantly treated esophageal cancer into 2 subgroups with markedly different outcomes. A p53 Research Group study.
Daniela Kandioler, Sebastian F Schoppmann, Ronald Zwrtek, Sonja Kappel, Brigitte Wolf

J Thorac Cardiovasc Surg· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Growing clinical evidence for the interaction of the p53 genotype and response to induction chemotherapy in advanced non-small cell lung cancer.
Daniela Kandioler, Georgios Stamatis, Wilfried Eberhardt, Sonja Kappel, Sabine Zöchbauer-Müller, Ronald Zwrtek

J Thorac Cardiovasc Surg· May 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TP53 genotype but not p53 immunohistochemical result predicts response to preoperative short-term radiotherapy in rectal cancer.
Daniela Kandioler, Ronald Zwrtek, Carmen Ludwig, Elisabeth Janschek, Meinhard Ploner

Ann Surg· April 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis